Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health
Helus Pharma partnered with TARA Mind and Veterans Exploring Treatment Solutions (VETS) to accelerate recruitment for the Phase 3 PARADIGM trial of its lead asset HLP003 for Major Depressive Disorder. The collaboration aligns with President Trump’s recent Executive Order focused on expanding access to breakthrough mental health treatments for veterans.
Key figures
- Drug Name
- HLP003
- Phase Of Trial
- Phase 3
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.